OHI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

287.18M

+24.42%

0.479

+16.78%

281.18M

+23.12%

0.476

+44.36%

285.37M

+21.13%

0.478

+3.82%

Estimates Revision

The market is revising Upward the revenue expectations for Omega Healthcare Investors, Inc. (OHI) for FY2025, with the revenue forecasts being adjusted by 5.76% over the past three months. During the same period, the stock price has changed by 11.07%.

Revenue Estimates for FY2025

Revise Upward

+5.76%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+8.72%

In Past 3 Month

Stock Price

Go Up

+11.07%

In Past 3 Month

12 Analyst Rating

Wall Street analysts forecast OHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OHI is 45.73 USD with a low forecast of 40.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

6 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

40.00

Averages

45.73

High

50.00

Current: 0.000

Low

40.00

Averages

45.73

High

50.00

BMO Capital

Outperform -> Market Perform

downgrade

$45

2026-01-09

New

Reason

BMO Capital

Price Target

$45

2026-01-09

New

downgrade

Outperform -> Market Perform

Reason

BMO Capital downgraded Omega Healthcare to Market Perform from Outperform with an unchanged price target of $45. BMO adjusted real estate investment trust ratings as part of its 2026 outlook. The firm sees limited upside to Omega's 2026 guidance and recommends taking profits at current share levels.

Goldman Sachs

Julien Blouin

initiated

$54

2026-01-09

New

Reason

Goldman Sachs

Julien Blouin

Price Target

$54

2026-01-09

New

initiated

Reason

Goldman Sachs analyst Julien Blouin initiated coverage of Omega Healthcare with a Buy rating and $54 price target. Channel checks and modeling point to meaningful upside in senior housing occupancy, RevPOR, and margins, though gains are likely capped longer term by vacancy, affordability, and supply, while also improving cash flow visibility for NNN structures and senior housing REIT investment opportunities, the analyst tells investors in a research note. Goldman expects the company to continue its shift towards Senior Housing NNN over time via acquisitions.

UBS

Buy

maintain

$50 -> $51

2026-01-08

New

Reason

UBS

Price Target

$50 -> $51

2026-01-08

New

maintain

Buy

Reason

UBS raised the firm's price target on Omega Healthcare to $51 from $50 and keeps a Buy rating on the shares. 2026 is expected to mark a pivotal REIT turnaround, with forecast total returns of 9%-11% driven by improving macro conditions, attractive valuations, easing supply pressures, and a more stable political backdrop, the analyst tells investors in a research note. The outlook points to a bifurcated year with defensiveness in the first half of 2026 and stronger catalysts in the second half, favoring Healthcare, Shopping Centers, and Coastal Apartments, UBS says.

Jefferies

Hold

maintain

$43 -> $45

2025-12-15

Reason

Jefferies

Price Target

$43 -> $45

2025-12-15

maintain

Hold

Reason

Jefferies raised the firm's price target on Omega Healthcare to $45 from $43 and keeps a Hold rating on the shares as part of a broader research note previewing 2026 for Healthcare REITs. The firm expects another challenging year for lab landlords as elevated market vacancy and a 9.6% decline in trailing-12-month biotech funding will drive below-average retention in 2026, the analyst tells investors in a research note. For Omega, Jefferies warns that the REIT has a high bar for acquisition volume that it may have trouble clearing while also trading at a reasonable valuation.

Truist

Michael Lewis

Hold

maintain

$44 -> $46

2025-12-02

Reason

Truist

Michael Lewis

Price Target

$44 -> $46

2025-12-02

maintain

Hold

Reason

Truist analyst Michael Lewis raised the firm's price target on Omega Healthcare to $46 from $44 and keeps a Hold rating on the shares. The stock has surged 16% in the past month versus 3% for the VNQ ETF, and is trading near its highest price to FFO multiple in more than a decade, which appears roughly fair given the favorable fundamentals and healthy forecasted earnings growth, the analyst tells investors in a research note.

Wells Fargo

Overweight

maintain

$45 -> $48

2025-11-25

Reason

Wells Fargo

Price Target

$45 -> $48

2025-11-25

maintain

Overweight

Reason

Wells Fargo raised the firm's price target on Omega Healthcare to $48 from $45 and keeps an Overweight rating on the shares. The firm says that despite a few high-profile exceptions, most REITs delivered Q3 2025 earnings and outlooks reflecting healthy operating conditions despite macro and labor market concerns.

Valuation Metrics

The current forward P/E ratio for Omega Healthcare Investors Inc (OHI.N) is 23.20, compared to its 5-year average forward P/E of 21.59. For a more detailed relative valuation and DCF analysis to assess Omega Healthcare Investors Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

21.59

Current PE

23.20

Overvalued PE

24.37

Undervalued PE

18.81

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

13.60

Current EV/EBITDA

14.89

Overvalued EV/EBITDA

14.36

Undervalued EV/EBITDA

12.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

9.36

Current PS

11.52

Overvalued PS

10.65

Undervalued PS

8.06

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 251.64% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

OHI News & Events

Events Timeline

No data

News

9.5

01-06Businesswire

PinnedOmega Healthcare Schedules Q4 2025 Earnings Release for February 4, 2026

5.0

2025-12-18Newsfilter

Maplewood Senior Living Appoints New Co-CEOs to Drive Luxury Senior Care Innovation

8.5

2025-12-13Newsfilter

KBW Announces Q4 2025 Index Rebalancing with Changes Across Six Indices

People Also Watch

Frequently Asked Questions

What is Omega Healthcare Investors Inc (OHI) stock price today?

The current price of OHI is 44.65 USD — it has decreased -0.07 % in the last trading day.

What is Omega Healthcare Investors Inc (OHI)'s business?

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.

What is the price predicton of OHI Stock?

What is Omega Healthcare Investors Inc (OHI)'s revenue for the last quarter?

Omega Healthcare Investors Inc revenue for the last quarter amounts to 311.59M USD, increased 12.88 % YoY.

What is Omega Healthcare Investors Inc (OHI)'s earnings per share (EPS) for the last quarter?

Omega Healthcare Investors Inc. EPS for the last quarter amounts to 0.59 USD, increased 40.48 % YoY.

What changes have occurred in the market's expectations for Omega Healthcare Investors Inc (OHI)'s fundamentals?

How many employees does Omega Healthcare Investors Inc (OHI). have?

Omega Healthcare Investors Inc (OHI) has 60 emplpoyees as of January 09 2026.

What is Omega Healthcare Investors Inc (OHI) market cap?

Today OHI has the market capitalization of 13.20B USD.